ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 31st, there was short interest totalling 7,600 shares, a decrease of 54.8% from the October 15th total of 16,800 shares. Based on an average daily trading volume, of 11,400 shares, the days-to-cover ratio is currently 0.7 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in ProShares Ultra Nasdaq Biotechnology stock. Texas Capital Bank Wealth Management Services Inc bought a new position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 5,000 shares of the exchange traded fund’s stock, valued at approximately $288,000. Texas Capital Bank Wealth Management Services Inc owned approximately 0.31% of ProShares Ultra Nasdaq Biotechnology as of its most recent filing with the SEC.
ProShares Ultra Nasdaq Biotechnology Stock Performance
NASDAQ BIB traded down $5.31 on Friday, reaching $53.66. The stock had a trading volume of 28,845 shares, compared to its average volume of 23,659. The firm has a fifty day moving average of $63.48 and a two-hundred day moving average of $61.83. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $42.42 and a 1-year high of $69.56.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Further Reading
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- What is Forex and How Does it Work?
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- What is Put Option Volume?
- Top-Performing Non-Leveraged ETFs This Year
- The Most Important Warren Buffett Stock for Investors: His Own
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.